NEXTURNBIOSCIENCE Co., Ltd. (KOSDAQ: 089140)

NEXTURNBIOSCIENCE Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2010
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2010
Cash & Equivalents	10,227	13,737	10,644	20,632	52,700	-
Short-Term Investments	2,200	2,260	12,425	11,500	-	-
Trading Asset Securities	19,147	15,144	5,078	9,051	1,260	-
Cash & Short-Term Investments	31,574	31,141	28,147	41,184	53,960	5,935
Cash Growth	-24.56%	10.64%	-31.66%	-23.68%	809.25%	45.31%
Accounts Receivable	5,030	6,713	5,963	2,753	3,085	-
Other Receivables	573.76	958.61	2,081	1,229	-	-
Receivables	10,336	8,701	8,353	4,301	4,788	-
Inventory	8,160	6,247	7,023	5,352	6,982	-
Prepaid Expenses	68.9	75.47	121.12	51.8	19.25	-
Other Current Assets	170.76	612.59	322.12	57.62	1,037	-
Total Current Assets	50,310	46,777	43,966	50,946	66,786	-
Property, Plant & Equipment	27,490	27,955	28,628	12,662	16,043	-
Long-Term Investments	79,765	83,476	42,099	55,221	3,650	-
Goodwill	1,656	1,656	1,656	-	-	-
Other Intangible Assets	976.11	1,168	2,205	123.23	136.15	-
Long-Term Accounts Receivable	81,951	81,191	80,238	-	-	-
Long-Term Deferred Tax Assets	-	-	-	509.21	798.98	-
Long-Term Deferred Charges	0	0	0	0	0	-
Other Long-Term Assets	2,272	1,771	1,466	19,487	11,937	-
Total Assets	244,435	243,994	200,257	138,949	99,351	-
Accounts Payable	2,139	2,882	4,147	946.83	717.07	-
Accrued Expenses	480.16	555.68	593.37	236.14	118.81	-
Short-Term Debt	17,274	10,846	8,236	25,456	-	-
Current Portion of Long-Term Debt	-	64,375	625	-	-	-
Current Portion of Leases	716.19	798.78	803.49	732.96	22.52	-
Current Income Taxes Payable	68.34	3,274	8.2	127.62	-	-
Current Unearned Revenue	46.44	87.83	42.71	-	40.02	-
Other Current Liabilities	3,250	10,854	5,246	15,718	1,170	-
Total Current Liabilities	23,974	93,672	19,702	43,218	2,069	-
Long-Term Debt	64,000	-	64,375	-	-	-
Long-Term Leases	450.24	749.74	1,519	2,186	17.87	-
Long-Term Deferred Tax Liabilities	6,802	6,553	2,046	-	-	-
Other Long-Term Liabilities	5,121	5,006	3,922	578.85	304.8	-
Total Liabilities	100,487	105,981	91,983	46,214	2,583	-
Common Stock	28,207	23,509	19,427	16,610	5,923	-
Additional Paid-In Capital	64,062	61,033	45,093	35,733	46,494	-
Retained Earnings	51,334	53,083	43,821	46,734	51,341	-
Treasury Stock	-81.25	-81.25	-	-6,990	-6,990	-
Comprehensive Income & Other	428.2	470	-66.18	646.76	-0	-
Shareholders' Equity	143,949	138,014	108,274	92,735	96,768	21,617
Total Liabilities & Equity	244,435	243,994	200,257	138,949	99,351	-
Total Debt	82,440	76,769	75,558	28,375	40.39	-
Net Cash (Debt)	-50,866	-45,628	-47,412	12,808	53,920	5,935
Net Cash Growth	-	-	-	-76.25%	808.57%	45.31%
Net Cash Per Share	-4942.02	-4523.61	-6984.29	1997.46	8408.77	-
Filing Date Shares Outstanding	11.28	9.4	7.77	6.41	6.41	-
Total Common Shares Outstanding	11.28	9.4	7.77	6.41	6.41	-
Working Capital	26,336	-46,895	24,264	7,728	64,717	-
Book Value Per Share	12765.79	14686.92	13933.75	14462.04	15090.95	4471.76
Tangible Book Value	141,317	135,190	104,414	92,612	96,632	21,428
Tangible Book Value Per Share	12532.40	14386.39	13436.98	14442.82	15069.72	4432.59
Land	19,143	19,143	19,143	5,013	9,767	-
Buildings	7,938	7,938	8,071	4,426	6,661	-
Machinery	9,927	9,625	11,114	5,451	5,497	-
Construction In Progress	51	82.5	-	-	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.